Search research articles
Contact Us
Filters
Showing results (11-20 of 193) with videos related to
Page
of 20
Sort By:
Therapeutics and Clinical Risk Management
|
May 14, 2009
Role of oxaliplatin in the treatment of colorectal cancer
Pasquale Comella, Rossana Casaretti, Claudia Sandomenico, et al.
Drugs
|
May 7, 2008
Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence
Pasquale Comella, Rossana Casaretti, Claudia Sandomenico, et al.
The International Journal of Biochemistry & Cell Biology
|
June 10, 2015
A perspective on the current treatment strategies for locally advanced rectal cancer
Antonio Avallone, Luigi Aloj, Giuseppe Aprile, et al.
Anticancer Research
|
October 3, 2022
Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy
Antonio Avallone, Sabrina Bimonte, Claudia Cardone, et al.
Critical Reviews in Oncology/Hematology
|
August 19, 2007
Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials
Pasquale Comella, Antonio Gambardella, Giuseppe Frasci, et al.
Cancer Treatment and Research
|
October 12, 2013
New perspective for an old antidiabetic drug: metformin as anticancer agent
Alessandra Leone, Elena Di Gennaro, Francesca Bruzzese, et al.
Critical Reviews in Oncology/Hematology
|
March 25, 2026
Blood-based circulating tumour DNA (ctDNA) tests for colorectal cancer screening: Systematic review and meta-analysis of diagnostic accuracy
Fabio Carbone, Davide Ciardiello, Stefano Granieri, et al.
Expert Opinion on Drug Safety
|
October 8, 2013
Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed
Antonio Avallone, Elena Di Gennaro, Lucrezia Silvestro, et al.
Exploration of Targeted Anti-Tumor Therapy
|
July 5, 2024
Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity?
Nicola Normanno, Vincenza Caridi, Matteo Fassan, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 2012
XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study
Gerardo Rosati, Antonio Avallone, Giuseppe Aprile, et al.
Page
of 20
Search research articles
Search
Showing results (11-20 of 193) with videos related to
Sort By:
Page
of 20
Therapeutics and Clinical Risk Management
|
May 14, 2009
Role of oxaliplatin in the treatment of colorectal cancer
Pasquale Comella, Rossana Casaretti, Claudia Sandomenico, et al.
Drugs
|
May 7, 2008
Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence
Pasquale Comella, Rossana Casaretti, Claudia Sandomenico, et al.
The International Journal of Biochemistry & Cell Biology
|
June 10, 2015
A perspective on the current treatment strategies for locally advanced rectal cancer
Antonio Avallone, Luigi Aloj, Giuseppe Aprile, et al.
Anticancer Research
|
October 3, 2022
Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy
Antonio Avallone, Sabrina Bimonte, Claudia Cardone, et al.
Critical Reviews in Oncology/Hematology
|
August 19, 2007
Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials
Pasquale Comella, Antonio Gambardella, Giuseppe Frasci, et al.
Cancer Treatment and Research
|
October 12, 2013
New perspective for an old antidiabetic drug: metformin as anticancer agent
Alessandra Leone, Elena Di Gennaro, Francesca Bruzzese, et al.
Critical Reviews in Oncology/Hematology
|
March 25, 2026
Blood-based circulating tumour DNA (ctDNA) tests for colorectal cancer screening: Systematic review and meta-analysis of diagnostic accuracy
Fabio Carbone, Davide Ciardiello, Stefano Granieri, et al.
Expert Opinion on Drug Safety
|
October 8, 2013
Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed
Antonio Avallone, Elena Di Gennaro, Lucrezia Silvestro, et al.
Exploration of Targeted Anti-Tumor Therapy
|
July 5, 2024
Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity?
Nicola Normanno, Vincenza Caridi, Matteo Fassan, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 2012
XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study
Gerardo Rosati, Antonio Avallone, Giuseppe Aprile, et al.
Page
of 20